Michelle Luo, PharmD, MS

Payer Strategy, Medical Value & Outcomes, Medical Affairs
Neurocrine Biosciences, Inc.

Poster(s):

• (363) Real-world insights on tardive dyskinesia: a claims-based analysis of demographics and healthcare utilization
  Wednesday, October 29, 2025